Organization
Biofabri
2 clinical trials
Clinical trial
Phase 2a Dose-Defining Safety and Immunogenicity Study of MTBVAC in South African Neonates Living in a High-Burden Tuberculosis-Endemic RegionStatus: Completed, Estimated PCD: 2022-05-19
2 clinical trials